We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYT
351
DELISTED
Syngenta Ag
SYT
| $4.85M | 0.05% |
+58,577
| New | +$4.61M |
|
352
Williams Companies
WMB
$90.5B
| $4.85M | 0.05% |
301,646
+182,249
| +153% | +$3.13M |
|
|
LLL
353
DELISTED
L3 Technologies, Inc.
LLL
| $4.84M | 0.05% |
40,885
-18,241
| -31% | -$2.13M |
|
354
Simpson Manufacturing
SSD
$7.98B
| $4.79M | 0.05% |
125,614
-157,473
| -56% | -$5.33M |
|
355
Edwards Lifesciences
EW
$47.6B
| $4.78M | 0.05% |
162,558
-108,375
| -40% | -$2.99M |
|
356
Regeneron Pharmaceuticals
REGN
$68.8B
| $4.76M | 0.05% |
13,220
+12,626
| +2,126% | +$5.2M |
|
357
MGM Resorts International
MGM
$11.7B
| $4.75M | 0.05% |
221,451
+206,537
| +1,385% | +$4.08M |
|
358
SiriusXM
SIRI
$10B
| $4.74M | 0.05% |
120,107
+108,932
| +975% | +$4.07M |
|
359
Ambev
ABEV
$47.3B
| $4.74M | 0.05% |
+915,599
| New | +$4.21M |
|
360
Donaldson
DCI
$10.8B
| $4.65M | 0.04% |
+145,812
| New | +$4.28M |
|
361
Fidelity National Financial
FNF
$13.9B
| $4.62M | 0.04% |
196,387
-439,074
| -69% | -$9.83M |
|
|
TMX
362
DELISTED
Terminix Global Holdings, Inc.
TMX
| $4.59M | 0.04% |
181,935
-373,234
| -67% | -$9.55M |
|
|
BWLD
363
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $4.58M | 0.04% |
+30,936
| New | +$4.73M |
|
364
Bread Financial
BFH
$4.21B
| $4.55M | 0.04% |
25,941
+16,995
| +190% | +$2.97M |
|
365
Steris
STE
$20.9B
| $4.54M | 0.04% |
63,888
-42,849
| -40% | -$2.9M |
|
|
ARG
366
DELISTED
Airgas Inc
ARG
| $4.52M | 0.04% |
31,923
+15,908
| +99% | +$2.23M |
|
367
Unilever
UL
$131B
| $4.45M | 0.04% |
87,552
+80,253
| +1,100% | +$3.9M |
|
368
Agilent Technologies
A
$39.1B
| $4.44M | 0.04% |
111,308
-44,017
| -28% | -$1.68M |
|
369
Zurn Elkay Water Solutions
ZWS
$8.07B
| $4.44M | 0.04% |
455,493
-475,614
| -51% | -$4.04M |
|
|
PPL
370
PPL Corp
PPL
$27.3B
| $4.4M | 0.04% |
+115,575
| New | +$4.11M |
|
371
Kinross Gold
KGC
$28.5B
| $4.39M | 0.04% |
+1,290,155
| New | +$3.2M |
|
372
Whirlpool
WHR
$2.42B
| $4.38M | 0.04% |
24,288
+8,756
| +56% | +$1.31M |
|
373
Ingredion
INGR
$6.38B
| $4.36M | 0.04% |
+40,781
| New | +$4.06M |
|
374
Carpenter Technology
CRS
$30B
| $4.34M | 0.04% |
+126,925
| New | +$3.74M |
|
|
NUVA
375
DELISTED
NuVasive, Inc.
NUVA
| $4.34M | 0.04% |
89,198
+2,657
| +3% | +$121K |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.